Laura A Leeson1, Ashley M Nelson2, Paul J Rathouz3, Mark B Juckett3, Christopher L Coe4, Elizabeth W Caes5, Erin S Costanzo1. 1. Department of Psychiatry, University of Wisconsin- Madison. 2. Department of Psychology, University of South Florida. 3. Carbone Cancer Center, University of Wisconsin-Madison and. 4. Department of Psychology, University of Wisconsin- Madison. 5. Carbone Cancer Center, University of Wisconsin-Madison.
Abstract
OBJECTIVE: Spirituality has been linked to improved adjustment and functioning in individuals with cancer; however, its effect on quality of life following hematopoietic stem cell transplantation (HSCT) has not been well-studied. This study investigated changes in spirituality in hematologic cancer patients recovering from HSCT and relationships between spirituality and dimensions of quality of life following HSCT. METHODS: Participants (N = 220) completed measures of two dimensions of spirituality (meaning/peace and religious faith), depression, anxiety, fatigue, pain, and physical and functional well-being prior to transplant and at 1-, 3-, 6-, and 12-months posttransplant. RESULTS: Meaning/peace declined at 1-month posttransplant and returned to pretransplant levels by 6-months posttransplant, and faith increased from pretransplant to 6-months posttransplant. Mixed-effects linear regression models indicated that greater pretransplant meaning/peace, but not religious faith, predicted less depression, anxiety, and fatigue, and better physical and functional well-being during the 12-months following transplant. CONCLUSIONS: The capacity to find meaning and peace may facilitate recovery following HSCT. Results suggest that spirituality may be a resilience factor that could be targeted to improve quality of life for HSCT recipients. (c) 2015 APA, all rights reserved).
OBJECTIVE: Spirituality has been linked to improved adjustment and functioning in individuals with cancer; however, its effect on quality of life following hematopoietic stem cell transplantation (HSCT) has not been well-studied. This study investigated changes in spirituality in hematologic cancerpatients recovering from HSCT and relationships between spirituality and dimensions of quality of life following HSCT. METHODS:Participants (N = 220) completed measures of two dimensions of spirituality (meaning/peace and religious faith), depression, anxiety, fatigue, pain, and physical and functional well-being prior to transplant and at 1-, 3-, 6-, and 12-months posttransplant. RESULTS: Meaning/peace declined at 1-month posttransplant and returned to pretransplant levels by 6-months posttransplant, and faith increased from pretransplant to 6-months posttransplant. Mixed-effects linear regression models indicated that greater pretransplant meaning/peace, but not religious faith, predicted less depression, anxiety, and fatigue, and better physical and functional well-being during the 12-months following transplant. CONCLUSIONS: The capacity to find meaning and peace may facilitate recovery following HSCT. Results suggest that spirituality may be a resilience factor that could be targeted to improve quality of life for HSCT recipients. (c) 2015 APA, all rights reserved).
Authors: Michael A Andrykowski; Michelle M Bishop; Elizabeth A Hahn; David F Cella; Jennifer L Beaumont; Marianne J Brady; Mary M Horowitz; Kathleen A Sobocinski; J Douglas Rizzo; John R Wingard Journal: J Clin Oncol Date: 2005-01-20 Impact factor: 44.544
Authors: M A Andrykowski; J S Carpenter; C B Greiner; E M Altmaier; T G Burish; J H Antin; R Gingrich; M J Cordova; P J Henslee-Downey Journal: Bone Marrow Transplant Date: 1997-10 Impact factor: 5.483
Authors: Samantha G Farris; Michael J Zvolensky; Matthew Tyler Boden; Marcel O Bonn-Miller Journal: J Addict Med Date: 2014 Mar-Apr Impact factor: 3.702
Authors: D M Hann; P B Jacobsen; L M Azzarello; S C Martin; S L Curran; K K Fields; H Greenberg; G Lyman Journal: Qual Life Res Date: 1998-05 Impact factor: 4.147
Authors: Karen L Syrjala; Shelby L Langer; Janet R Abrams; Barry Storer; Jean E Sanders; Mary E D Flowers; Paul J Martin Journal: JAMA Date: 2004-05-19 Impact factor: 56.272
Authors: Lauren Z Davis; Michaela Cuneo; Premal H Thaker; Michael J Goodheart; David Bender; Susan K Lutgendorf Journal: Psychooncology Date: 2017-08-04 Impact factor: 3.894
Authors: Hermioni L Amonoo; Christina N Massey; Melanie E Freedman; Areej El-Jawahri; Halyna L Vitagliano; William F Pirl; Jeff C Huffman Journal: Psychosomatics Date: 2019-02-14 Impact factor: 2.386
Authors: Osama Abdalkareem Abdalrahman; Elham H Othman; Anas H Khalifeh; Khaled Hasan Suleiman Journal: Support Care Cancer Date: 2022-06-11 Impact factor: 3.359
Authors: Jennifer M Knight; Mallory R Taylor; Kelly E Rentscher; Elisabeth C Henley; Hannah A Uttley; Ashley M Nelson; Lucie M Turcotte; Natalie S McAndrew; Hermioni L Amonoo; Lathika Mohanraj; Debra Lynch Kelly; Erin S Costanzo Journal: Front Immunol Date: 2022-07-05 Impact factor: 8.786
Authors: Margaret Bevans; Areej El-Jawahri; D Kathryn Tierney; Lori Wiener; William A Wood; Flora Hoodin; Erin E Kent; Paul B Jacobsen; Stephanie J Lee; Matthew M Hsieh; Ellen M Denzen; Karen L Syrjala Journal: Biol Blood Marrow Transplant Date: 2016-09-19 Impact factor: 5.742
Authors: Kelly E Rentscher; Judith E Carroll; Mark B Juckett; Christopher L Coe; Aimee T Broman; Paul J Rathouz; Peiman Hematti; Erin S Costanzo Journal: J Natl Cancer Inst Date: 2021-10-01 Impact factor: 13.506